Immunology and Microbiology
Methicillin-Resistant Staphylococcus Aureus
78%
Staphylococcus Aureus
71%
Polymerase Chain Reaction
55%
Infectious Agent
47%
Peptoclostridium difficile
43%
Antibiotic Sensitivity
30%
Prevalence
27%
Clinical Microbiology
25%
Cytotoxicity
20%
Cell Culture
19%
Human Immunodeficiency Virus
18%
Matrix-Assisted Laser Desorption-Ionization
17%
Agar
17%
Enzyme Immunoassay
16%
Microorganism
16%
Electrospray Mass Spectrometry
16%
Time-of-Flight Mass Spectrometry
15%
Microbiology
15%
Antimicrobial Resistance
13%
Neutralization
13%
Soft Tissue
13%
Klebsiella pneumoniae
12%
Minimum Inhibitory Concentration
11%
Pseudomonas aeruginosa
11%
Gram-Negative Bacteria
11%
RNA Gene
11%
Mycobacteria
11%
Vancomycin-Resistant Enterococcus
10%
Streptococcus Pneumoniae
10%
Pig
9%
Methicillin Susceptible Staphylococcus Aureus
9%
Candida
9%
Direct Fluorescent Antibody
9%
Antigen-Antibody Interaction
8%
Bronchoalveolar Lavage Fluid
8%
Plasmid
8%
Turnaround Time
8%
Infectious Disease
8%
Influenza
8%
Pathogenicity
8%
Molecular Epidemiology
8%
Penicillin
8%
Nocardia
8%
Lower Respiratory Tract
8%
DNA Sequence
8%
Stenotrophomonas maltophilia
8%
Surface Property
8%
Bacterium Identification
7%
Type Strain
7%
Cerebrospinal Fluid
7%
Medicine and Dentistry
Infection
100%
Diagnosis
55%
Pathogen
38%
Antibiotics
35%
Disease
34%
Cohort Effect
29%
Peptoclostridium difficile
26%
Staphylococcus Aureus
24%
Severe Acute Respiratory Syndrome Coronavirus 2
22%
Blood Culture
21%
Clostridium Difficile Infection
21%
Bacteremia
17%
Antiinfective Agent
17%
Immunocompromised Patient
17%
Neonatal Intensive Care Unit
16%
Methicillin Resistant Staphylococcus Aureus
16%
Diarrhea
15%
Prevalence
15%
Intensive Care Unit
14%
Lower Respiratory Tract Infection
13%
Neonate
12%
Human Immunodeficiency Virus
12%
Gram-Negative Bacteria
12%
Polymerase Chain Reaction
11%
Vancomycin
9%
Cell Culture
8%
Bronchoalveolar Lavage Fluid
8%
Clinician
8%
Infection Prevention
8%
Sepsis
8%
Antibiotic Resistance
8%
Acinetobacter Baumannii
8%
Influenza A
8%
Carbapenem-Resistant Enterobacteriaceae
8%
Virus Infection
7%
Upper Respiratory Tract Infection
7%
Enzyme Immunoassay
7%
Antibiogram
7%
COVID-19
7%
Health Care Cost
7%
Polymerase Chain Reaction
7%
Soft Tissue Infection
7%
Transplantation
7%
Antigen Antibody Reaction
7%
Retrospective Cohort Study
7%
Laboratory Diagnosis
6%
Household
6%
Diagnostic Microbiology
6%
Symptom
6%
Antibiotic Therapy
6%
Keyphrases
Methicillin-resistant Staphylococcus Aureus
36%
Clostridioides Difficile
27%
Staphylococcus Aureus
22%
Epidemiology
18%
United States
17%
Soft Tissue Infection
16%
Blood Culture
15%
Diagnostic Stewardship
14%
Difficile
13%
Clostridium Difficile Infection
13%
Bacteremia
13%
Skin Tissue
13%
Vancomycin-resistant Enterococci
12%
Susceptibility Testing
12%
Staphylococcus Aureus Colonization
12%
Confidence Interval
11%
CA-MRSA
11%
Infectious Diseases Society of America
10%
Risk Factors
10%
Pediatric
9%
AIDS/HIV
9%
Pediatric Intensive Care Unit
8%
Enzyme-linked Immunosorbent Assay (ELISA)
8%
Skin Infection
8%
Infectious Diseases
8%
Rapid Detection
8%
Livestock-associated
8%
GenMark
8%
EPlex
8%
Infectious Disease Surveillance
8%
Blood Culture Identification
8%
Multidrug-resistant Staphylococcus Aureus
8%
Immunocompromised Host
8%
CHROMagar
8%
Molecular Epidemiology
8%
Microbiology Laboratory
8%
Nasal
7%
Vancomycin
7%
Industrial Hog Operation
7%
Laboratory Diagnosis
7%
Diarrhea
7%
Methicillin-resistant S. Aureus
7%
Neonate
6%
Turnaround Time
6%
Clinical Microbiology
6%
Baltimore
6%
COVID-19
6%
Hospitalized Patients
6%
Gram-negative
6%
Healthcare Workers
6%